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DrMarc Mitchell (Jackson, Miss). As I understand your data,
it demonstrates good results with both carotid endarterectomy and
carotid angioplasty and stenting in both men and women. I think
the data makes a strong argument that women benefit from carotid
interventions just as men do. On what basis do you conclude that
carotid angioplasty and stenting is superior to endarterectomy in
women?
Dr De Rango. Because there might be some women, as
asymptomatic women, who benefit less from carotid endarterec-
tomy and may better advantage from carotid angioplasty and
stenting. We did not find any difference in outcome between
genders after carotid endarterectomy when we analyzed women as
a whole. We did a subgroup comparison between genders stratified
by symptoms and, after carotid endarterectomy, and according to
our data, the risk of stroke in asymptomatic women was higher
than in asymptomatic men. On the contrary, there was no differ-
ence between genders in the perioperative and late stroke risk for
either asymptomatic or symptomatic subgroups of patients afterbe some subgroups of women who are still at high risk from
surgery and from carotid endarterectomy and could benefit from
stenting.
Dr Wei Zhou (Palo Alto, Calif). When we analyzed risk
factors for microemboli during carotid stenting, peripheral vascu-
lar disease was shown to be an independent predictor for contralat-
eral hemisphere subclinical microemboli. In your group, there
were many more patients with peripheral vascular diseases in the
male cohort than the female cohort. Would you please comment
on how this variable affected your outcome?
Dr De Rango. We did not find that the difference in distri-
bution of peripheral vascular disease affected outcome. Specifically,
in our multivariate analysis, there was no influence (“confounding
effect”) of peripheral disease on operative risks. We did not specif-
ically analyze outcome in the subgroup of patients with peripheral
disease who accounted for a small part of the overall population.
Multivariate analysis, however, failed to show an association be-
tween the presence of peripheral disease and the outcome.
